Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Alotec
2. Astmopent
3. Metaprel
4. Metaproterenol
5. Metaproterenol Polistirex
6. Metaproterenol Sulfate
7. Orciprenaline
8. Orciprenaline Sulfate
9. Polistirex, Metaproterenol
1. Prometa
2. Orciprenaline Sulphate
3. Th-152
4. Novasmasol
5. Metaprel
6. Alotec
7. [2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]-propan-2-ylazanium;sulfate
8. Gj20h50yf0
9. Einecs 227-539-6
10. Unii-gj20h50yf0
11. 1-(3,5-dihydroxyphenyl)-2-(isopropylamino)ethanol Sulfate
12. 1-(3,5-dihydroxyphenyl)-1-hydroxy-2-isopropylaminoethane Sulfate
13. Metaproterenol Sulfate [usan:usp]
14. 3,5-dihydroxy-alpha-((isopropylamino)methyl)benzyl Alcohol Sulfate
15. 3,5-dihydroxy-alpha-((isopropylamino)methyl)benzyl Alcohol Sulfate (2:1)
16. (+-)-3,5-dihydroxy-alpha-((isopropylamino)methyl)benzyl Alcohol Sulfate (2:1)
17. 1,3-benzenediol, 5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-, Sulfate (2:1) (salt)
18. 1,3-benzenediol, 5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-, Sulfate (2:1) Salt
19. 1,3-benzenediol, 5-(1-hydroxy-2-(1-methylethyl)amino)ethyl-, (+-)-, Sulfate (2:1) (salt)
20. Benzyl Alcohol, 3,5-dihydroxy-alpha-((isopropylamino)methyl)-, Sulfate (2:1) (salt)
Molecular Weight | 520.6 g/mol |
---|---|
Molecular Formula | C22H36N2O10S |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 8 |
Exact Mass | 520.20906652 g/mol |
Monoisotopic Mass | 520.20906652 g/mol |
Topological Polar Surface Area | 243 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 239 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Metaproterenol sulfate |
Drug Label | Metaproterenol sulfate syrup is an oral bronchodilator. Each teaspoonful (5 mL), for oral administration, contains metaproterenol sulfate 10 mg. In addition, each teaspoonful (5 mL) contains the following inactive ingredients:citric acid, edetate dis... |
Active Ingredient | Metaproterenol sulfate |
Dosage Form | Tablet; Syrup; Solution |
Route | Oral; Inhalation |
Strength | 10mg/5ml; 0.4%; 0.6%; 10mg; 20mg |
Market Status | Prescription |
Company | Wockhardt; Silarx; Mylan Speclt; Par Pharm |
2 of 2 | |
---|---|
Drug Name | Metaproterenol sulfate |
Drug Label | Metaproterenol sulfate syrup is an oral bronchodilator. Each teaspoonful (5 mL), for oral administration, contains metaproterenol sulfate 10 mg. In addition, each teaspoonful (5 mL) contains the following inactive ingredients:citric acid, edetate dis... |
Active Ingredient | Metaproterenol sulfate |
Dosage Form | Tablet; Syrup; Solution |
Route | Oral; Inhalation |
Strength | 10mg/5ml; 0.4%; 0.6%; 10mg; 20mg |
Market Status | Prescription |
Company | Wockhardt; Silarx; Mylan Speclt; Par Pharm |
Adrenergic beta-2 Receptor Agonists
Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS. (See all compounds classified as Adrenergic beta-2 Receptor Agonists.)
Bronchodilator Agents
Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
Sympathomimetics
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
Tocolytic Agents
Drugs that prevent preterm labor and immature birth by suppressing uterine contractions (TOCOLYSIS). Agents used to delay premature uterine activity include magnesium sulfate, beta-mimetics, oxytocin antagonists, calcium channel inhibitors, and adrenergic beta-receptor agonists. The use of intravenous alcohol as a tocolytic is now obsolete. (See all compounds classified as Tocolytic Agents.)
ABOUT THIS PAGE
A Novasmasol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Novasmasol, including repackagers and relabelers. The FDA regulates Novasmasol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Novasmasol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Novasmasol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Novasmasol supplier is an individual or a company that provides Novasmasol active pharmaceutical ingredient (API) or Novasmasol finished formulations upon request. The Novasmasol suppliers may include Novasmasol API manufacturers, exporters, distributors and traders.
click here to find a list of Novasmasol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Novasmasol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Novasmasol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Novasmasol GMP manufacturer or Novasmasol GMP API supplier for your needs.
A Novasmasol CoA (Certificate of Analysis) is a formal document that attests to Novasmasol's compliance with Novasmasol specifications and serves as a tool for batch-level quality control.
Novasmasol CoA mostly includes findings from lab analyses of a specific batch. For each Novasmasol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Novasmasol may be tested according to a variety of international standards, such as European Pharmacopoeia (Novasmasol EP), Novasmasol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Novasmasol USP).
LOOKING FOR A SUPPLIER?